Overexpression of GFAT activates PAI-1 promoter in mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 279, Issue 4 48-4, 2000, Pages

  James, Leighton R ^a   Fantus, I George ^b   Goldberg, Howard ^b   Ly, Hao ^a   Scholey, James W ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diabetic nephropathy; Gene expression; Glutamine:fructose 6 phosphate amidotransferase; Plasminogen activator inhibitor 1

Indexed keywords

GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL CELL; ARTICLE; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; MALE; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0033680164     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.279.4.f718     Document Type: Article

References (50)

1. The effect of intensive insulin treatment of diabetes on the development and progression of long-term insulin-dependent diabetes mellitus
2. Characterisation of the promoter region of the human transforming growth factor-beta type II receptor gene
3. Suppression of experimental glomerulonephritis by antiserum against TGF β1
4. Nonenzymatic giycosylation and the pathogenesis of diabetic complications
5. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects
6. Effects of overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells
7. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells
8. Single step method of RNA isolation by acid guanidium thiocynates-phenol-chloroform extraction
9. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression
10. Mechanism of hexosamine-induced insulin resistance in mice overexpressing glutamine:fructose-6-phosphate amidotransferase: Decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione
11. Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine:fructose-6-phosphate amidotransferase in Rat-1 fibroblast
12. Regulation of glycogen synthase by glucose, glucosamine, and glutamine:fructose-6-phosphate amidotransferase
13. Transcriptional regulation of transforming growth factor beta 1 by glucose: Investigation into the role of the hexosamine biosynthetic pathway
14. Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy
15. Protein kinase C and high glucose stimulate collagen α I (IV) transcriptional activity in a reporter mesangial cell line
16. Regulation of the transforming growth factor-beta 1 and -beta 3 promoters by transcription factor Sp1
17. Type 1 (RI) and type II (RII) receptor for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound repair
18. Glucosamine stimulates plasminogen activator inhibitor-1 (PAI-1) promoter activity via Sp1, independent of transforming growth factor-β (TGF-β)
19. Effects of polyol pathway inhibition and dietary myo-inositol on giomerular hemodynamic function in experimental diabetes mellitus in rats
20. Reduced O-glycosylation of Sp1 is associated with increased proteasome susceptibility
21. Proteoglycan core protein families
22. The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake
23. Overexpression of glutamine:fructose-6-phosphate amido-transferase in transgenic mice leads to insulin resistance
24. Glucosamine induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP
25. Cyclin and cyclin dependent kinase expression in the remnant glomerulus
26. Multiple and essential binding sites in the promoter for transforming growth factor-beta type I receptor
27. Characterization of the promoter region of the human transforming growth factor-beta 1 gene
28. High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine mesangial cells
29. Glucosamine induces translocation of PKC isoenzymes in ruesangial cells
30. Dynamic glycosylation of nuclear and cytosolic proteins
31. Plasminogen activator inhibitors: A review
32. Identification of disulphide-linked transforming growth factor-β1 specific binding proteins in rat glomeruli
33. Discovery of the metabolic pathway mediating glucose-induced desensitization of the glucose transport system
34. Receptors for the TGF-β family
35. Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor β1 on gene expression
36. Expression of glutamine:fructose-6-phosphate amidotransferase in human tissue
37. Expression of TGF-beta receptors type I and II in human glomerulonephritis
38. Distribution of glutamine hexophosphate amidotransferase in rat tissues
39. Role of glucosamine in the stimulation of TGF-α gene transcription by glucose and EGF
40. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene
41. Glucosamine infusion in rats mimics the β-cell dysfunction of non-insulin-dependent diabetes mellitus
42. Increased glomerular capillary pressure alters glomerular cytokine expression
43. Expression of transforming growth factor β1 during diabetic renal hypertrophy
44. Increased plasminogen activator inhibitor type I in coronary artery atherotomy specimens from type 2 diabetic compared with nondiabetic patients
45. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat
46. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-β isoforms and their receptors following arterial injury
47. TGFβ signals through heteromeric protein kinase receptor complex
48. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy
49. Expression of type I II and III TGF-beta receptors in human glomerulonephritis
50. Transforming growth factor β protein and mRNA in glomeruli in normal and diseased human kidneys